EE04316B1 - Asolotriasiinid ja -pürimidiinid, neid sisaldavadfarmatseutilised kompositsioonid ning nende kasutamine ravimite valmistamiseks - Google Patents

Asolotriasiinid ja -pürimidiinid, neid sisaldavadfarmatseutilised kompositsioonid ning nende kasutamine ravimite valmistamiseks

Info

Publication number
EE04316B1
EE04316B1 EEP199900019A EE9900019A EE04316B1 EE 04316 B1 EE04316 B1 EE 04316B1 EE P199900019 A EEP199900019 A EE P199900019A EE 9900019 A EE9900019 A EE 9900019A EE 04316 B1 EE04316 B1 EE 04316B1
Authority
EE
Estonia
Prior art keywords
azolotriazines
pyrimidines
medicaments
manufacture
pharmaceutical compositions
Prior art date
Application number
EEP199900019A
Other languages
English (en)
Estonian (et)
Other versions
EE9900019A (et
Inventor
Georgios Arvanitis Argyrios
John Chorvat Robert
Original Assignee
Dupont Pharmaceuticals Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dupont Pharmaceuticals Company filed Critical Dupont Pharmaceuticals Company
Priority claimed from PCT/US1997/013072 external-priority patent/WO1998003510A1/en
Priority claimed from US08/899,242 external-priority patent/US6124289A/en
Publication of EE9900019A publication Critical patent/EE9900019A/xx
Publication of EE04316B1 publication Critical patent/EE04316B1/xx

Links

EEP199900019A 1996-07-24 1997-07-23 Asolotriasiinid ja -pürimidiinid, neid sisaldavadfarmatseutilised kompositsioonid ning nende kasutamine ravimite valmistamiseks EE04316B1 (et)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US68604796A 1996-07-24 1996-07-24
US2329096P 1996-07-24 1996-07-24
PCT/US1997/013072 WO1998003510A1 (en) 1996-07-24 1997-07-23 AZOLO TRIAZINES AND PYRIMIDINES
US08/899,242 US6124289A (en) 1996-07-24 1997-07-23 Azolo triazines and pyrimidines

Publications (2)

Publication Number Publication Date
EE9900019A EE9900019A (et) 1999-08-16
EE04316B1 true EE04316B1 (et) 2004-06-15

Family

ID=27362048

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP199900019A EE04316B1 (et) 1996-07-24 1997-07-23 Asolotriasiinid ja -pürimidiinid, neid sisaldavadfarmatseutilised kompositsioonid ning nende kasutamine ravimite valmistamiseks

Country Status (15)

Country Link
JP (2) JP4704521B2 (zh)
CN (3) CN1104432C (zh)
AR (1) AR049583A2 (zh)
BR (1) BR9710544A (zh)
CA (1) CA2259583C (zh)
CZ (1) CZ299451B6 (zh)
EA (1) EA004403B1 (zh)
EE (1) EE04316B1 (zh)
HR (1) HRP970413A2 (zh)
IL (4) IL127871A0 (zh)
NO (1) NO315610B3 (zh)
NZ (1) NZ333777A (zh)
PL (1) PL195762B1 (zh)
SI (1) SI9720045B (zh)
SK (1) SK286461B6 (zh)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002072202A1 (en) * 2001-03-13 2002-09-19 Bristol-Myers Squibb Pharma Company 4-(2-butylamino)-2,7-dimethyl-8-(2-methyl-6-methoxypyrid-3-yl) pyrazolo-[1,5-a]-1,3,5-triazine, its enantiomers and pharmaceutically acceptable salts as corticotropin releasing factor receptor ligands
WO2004110454A1 (ja) * 2003-06-13 2004-12-23 Ishihara Sangyo Kaisha, Ltd. アデノシンＡ2ａ受容体アゴニストの投与が必要な疾患を治療又は予防するための組成物
US7329662B2 (en) * 2003-10-03 2008-02-12 Hoffmann-La Roche Inc. Pyrazolo-pyridine
GB0519957D0 (en) * 2005-09-30 2005-11-09 Sb Pharmco Inc Chemical compound
DK2094709T3 (da) * 2006-09-20 2010-12-06 Lilly Co Eli Thiazol-pyrazolopyrimidiner som CRF1-receptorantagonister
CN103694242B (zh) * 2013-12-10 2016-01-06 昆明翔昊科技有限公司 吡唑并嘧啶类化合物及其药物组合物和其在制药中的应用
EP3628005A4 (en) 2017-08-14 2021-01-20 Spruce Biosciences, Inc. CORTICOTROPIN RELEASE FACTOR RECEPTOR ANTAGONISTS
CN112479956A (zh) * 2019-07-30 2021-03-12 杭州阿诺生物医药科技有限公司 一种用于制备腺苷受体抑制剂中间体的方法
WO2022036123A1 (en) 2020-08-12 2022-02-17 Spruce Biosciences, Inc. Methods and compositions for treating polycystic ovary syndrome
US11708372B2 (en) 2021-11-19 2023-07-25 Spruce Biosciences, Inc. Crystalline composition of tildacerfont and methods of use and preparation thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3995039A (en) * 1975-05-27 1976-11-30 Merck & Co., Inc. Pyrazolo [1,5-a] [1,3,5] triazines
JPS6157587A (ja) * 1984-08-29 1986-03-24 Shionogi & Co Ltd 縮合複素環誘導体および抗潰瘍剤
US4824834A (en) * 1986-10-31 1989-04-25 Otsuka Pharmaceutical Company, Limited Pyrazolotriazine compounds
JP2691317B2 (ja) * 1989-08-25 1997-12-17 株式会社大塚製薬工場 ４―ヒドロキシ―８―（３―低級アルコキシ―４―フェニルスルフィニルフェニル）ピラゾロ〔１，５―ａ〕―１，３，５―トリアジン光学活性体の塩類及びその製造方法
US5420128A (en) * 1990-10-09 1995-05-30 Otsuka Pharmaceutical Co., Ltd. Pyrimidine derivatives, method of manufacturing the same, and androgen inhibitor
DE69130683T2 (de) * 1991-04-22 1999-05-06 Otsuka Pharmaceutical Factory, Inc., Naruto, Tokushima PYRAZOLO[1,5-a]PYRIMIDINDERIVATE UND SIE ENTHALTENDE ANTIINFLAMMATORISCHE MITTEL
US5356897A (en) * 1991-09-09 1994-10-18 Fujisawa Pharmaceutical Co., Ltd. 3-(heteroaryl)-pyrazololi[1,5-a]pyrimidines

Also Published As

Publication number Publication date
NZ333777A (en) 2000-07-28
HRP970413A2 (en) 1998-10-31
IL164513A0 (en) 2005-12-18
CN1250223C (zh) 2006-04-12
CZ18499A3 (cs) 1999-11-17
IL127871A (en) 2010-04-29
JP2005097257A (ja) 2005-04-14
IL127871A0 (en) 1999-10-28
SK9799A3 (sk) 2005-04-01
NO315610B1 (no) 2003-09-29
SI9720045A (sl) 1999-10-31
EA199900158A1 (ru) 1999-10-28
NO990264L (no) 1999-03-10
CN1327793A (zh) 2001-12-26
CZ299451B6 (cs) 2008-07-30
CN1225637A (zh) 1999-08-11
JP4194539B2 (ja) 2008-12-10
SI9720045B (sl) 2008-02-29
NO315610B3 (no) 2003-09-29
EE9900019A (et) 1999-08-16
EA004403B1 (ru) 2004-04-29
JP2002513382A (ja) 2002-05-08
AR049583A2 (es) 2006-08-16
SK286461B6 (sk) 2008-10-07
IL164513A (en) 2010-04-29
NO990264D0 (no) 1999-01-21
PL195762B1 (pl) 2007-10-31
CN1388126A (zh) 2003-01-01
IL150163A (en) 2010-12-30
BR9710544A (pt) 1999-08-17
CN1104432C (zh) 2003-04-02
PL331523A1 (en) 1999-07-19
JP4704521B2 (ja) 2011-06-15
CA2259583A1 (en) 1998-01-29
CA2259583C (en) 2009-11-17

Similar Documents

Publication Publication Date Title
EE04282B1 (et) Pürasoolpürimidiinid, nende valmistamine ja kasutamine ravimina ning neid sisaldav kompositsioon
EE200400059A (et) Diarüültsükloalküülderivaadid, nende kasutamine ravimite valmistamiseks ning neid sisaldav ravim
EE04354B1 (et) Indolüül-3-glüoksüülhappe derivaadid, nende kasutamine ravimite valmistamiseks ja neid sisaldavad kasvajavastase toimega ravimid
EE04965B1 (et) Imidasoimidasoolid ja triasoolid kui p?letikuvastased hendid, nende kasutamine ravimite valmistamiseks ning farmatseutiline kompositsioon
ID22565A (id) Penggunaan nanodispersi dalam formulasi akhir obat
DE69928260D1 (de) Schwefel-substituierte sulfonylaminocarbonsäure n-arylamide, ihre herstellung, ihre anwendung und diese enthaltende pharmazeutische zusammensetzungen
MA26553A1 (fr) Alpha-aryl-n-alkylnitrones et compositions pharmaceutiques contenant ceux-la
DE69822209D1 (de) ESTRON-SULFatase HEMMENDE ESTRON-SULFAMATVERBINDUNGEN, PHARMAZEUTISCHE ZUSAMMENSETZUNGEN UND VERWENDUNGEN DAVON
LV12624A (lv) Thienylazolylalcoxyethanamines their preparation and their application as medicaments
HUP0103884A3 (en) Arylsulfonanilide urea-derivatives, pharmaceutical compositions containing them and their use
EE200000037A (et) Atsüülpiperasinüülpürimidiinide derivaadid, nende valmistamine ja kasutamine ravimitena
DE59905572D1 (de) Substituierte 4-amino-2-aryl-pyrimidine, ihre herstellung, ihre verwendung und sie enthaltende pharmazeutische präparate
DE69830119D1 (de) Teigzusammensetzung und derer Herstellung
EE200200271A (et) Ravimkombinatsioonid ning nende kasutamine
HUP9802132A3 (en) Biphenyl-sulfonyl-cyanamides, their use and pharmaceutical compositions containing them
EE04316B1 (et) Asolotriasiinid ja -pürimidiinid, neid sisaldavadfarmatseutilised kompositsioonid ning nende kasutamine ravimite valmistamiseks
EE9900034A (et) Arüültsükloalkaankarboksüülestrid, nende kasutamine, farmatseutilised kompositsioonid ja valmistamine
HUP0104852A3 (en) Oktahydro-pyrido-pyrazine derivatives and pharmaceutical compositions containing the same and their use
BR0012184B1 (pt) compostos derivados de indol, formulação farmacêutica, e, composição e uso dos compostos na fabricação de medicamentos
DE69312319D1 (de) Tachyquinin antagonisten, ihre herstellung und ihre verwendung in pharmazeutischen formulierungen
NO20001717D0 (no) Serotonin-inneholdende formulering for oral administrering og anvendelse av samme
HUP0104834A3 (en) Sulphonyloxazolamines, their use, pharmaceutical compositions containing them and their preparation
ATE270272T1 (de) C11-oxymyl- and hydroxylamino-prostaglandine und ihre anwendung als arzneimittel
EE9700230A (et) Bitsüklilised tahhükiniini antagonistid, nende valmistamine ja kasutamine ravimsegus
NO20014692L (no) 3-amidinobenzensulfonamidderivater, medisinske sammensetninger inneholdende slike samt intermediater vedfremstillingen derav

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20041231

LD4A Amendment in the specification
KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20101231